The ~Tulip® is a small, oropharyngeal airway that directly replaces the Guedel and Facemask technique for all users and all first-line airway interventions, even in semi-conscious patients. This is not possible with any other ventilating airway, as the patient usually needs to be fully unconscious before any supraglottic devices can be introduced.
This is a major advantage, as early ~Tulip® use prevents any further patient deterioration in the first instance.
Equally, the ~Tulip® may be used for first-line airway intervention, starved-elective anaesthesia, endotracheal intubation, endoscopy or nasogastric and orogastric tube insertion. The ~Tulip’s® large, oropharyngeal, balloon-like cuff is particularly advantageous in ENT and Dental surgery, as no endotracheal intubation is required because the ~Tulip’s® large, 30 – 60ml, high-volume, low-pressure cuff produces an airtight seal within the oropharynx, e.g., above the laryngeal inlet and below the level of the surgery.
Clinical trials have shown statistically significant results with the inexperienced, first-time users generating 77% bigger tidal volumes, 101% higher end-tidal CO2 readings, 36% higher ventilation pressures, and no failures with the ~Tulip® airway. This translates into 125 – 250% more Oxygen with hands-free, direct-connectability and a reduced dead-space volume in times of acute emergency, as adequate ventilation was achieved in 60 out of 60 users (100%) with the ~Tulip® airway.
This was statistically significant in favour of the ~Tulip® airway at a p < 0.001 level.
The analysis of the binary outcome data showed that the outcome of adequate ventilation in less than 60 seconds and within 2 attempts was achieved with 35 out of 60 (58.3%) of Guedel and Facemask users, demonstrating 10 out of 60 (16.7%) total failures, and 15 out of 60 (25%) inadequately ventilated patients. The end-tidal CO2 and tidal-volume outcomes were achieved in 56 of the 60 (93%) users with the ~Tulip® airway, but in only 16 of the 60 users (27%) with the Guedel and Facemask combination (p < 0.001).
10 of the 60 Guedel and Facemask users (17%) failed to ventilate the patient at all.
End-tidal carbon dioxide, tidal volume and peak inspiratory pressures were significantly better (p < 0.0001) for all parameters with the ~Tulip® airway.
The ~Tulip® airway was found to be easier to insert and demonstrated a steep learning curve. Thus, the ~Tulip® airway device should be considered as an adjunct to airway management both inside and outside hospital because the data now clearly shows that the ~Tulip® does not just make the impossible possible, the ~Tulip® makes the impossible easy for everybody.
In terms of user preference, 47 out of 60 (78%) of users favoured the ~Tulip® airway.
The ~Tulip® airway is a range of airway devices designed to allow anybody to resuscitate anyone anywhere. Even by family members and children > 8 yrs. of age because the ~Tulip® was specifically designed for both inexperienced and experienced users. This then allows life saving Basic Life Support (BLS) and Cardiopulmonary Resuscitation (CPR) intervention in any location.
Even in semi-conscious patients, or at home.
The ~Tulip® is a replacement for the Guedel and Facemask. It may be used for any airway intervention, including starved elective anaesthesia. The ~Tulip® is an oropharyngeal airway. It is not supraglottic. The ~Tulip® is much smaller in size. Therefore, the ~Tulip® may be used in semi-conscious patients because it is the smallest, softest (lowest cuff pressure), least invasive and least stimulating intermittent positive pressure ventilating (IPPV) airway available. The ~Tulip® is also hands-free and directly-connectable, which then allows the delivery of 100% O2 via a sealed-circuit for the provision of life support and airway maintenance. The ~ Tulip® is colour coded for size. It is available both with and without a headband.
The Objective
Airway management is usually conducted by medical professionals, but unfortunately most collapses and cardiac arrests happen outside the hospital, at home, where medical assistance is unlikely to arrive within the 3 – 5 minutes available. Consequently, everyone must be able to manage an airway and conduct BLS/CPR (Basic Life Support/Cardiopulmonary Resuscitation), otherwise the outcomes are likely to be negative because an uncomfortable fact is that out of hospital (OOH) cardiac arrest survival without neurological deficit is only 1.25 – 2.5% (10,000 patients over 10 years) at the moment.
The ~Tulip® is the first airway device designed for such wide-spread use, and as such the ~Tulip® may also be more easily used by medical professionals in Hospital settings. For example, in A+E/ER, on the Wards, by Paramedics in Ambulances, and for more complex cases such as starved elective anaesthesia because the ~Tulip® is the first airway that was designed for everybody.
The Guedel airway was invented in 1933. It is the hardest airway to use because of the difficult Facemask skills that are required, yet the least experienced airway users must still use it because no other alternatives have been available, until now.
The ~Tulip® airway addresses these issues head-on, as the ~Tulip® airway has been specifically designed to assist inexperienced users. However, the ~Tulip® is of benefit to consultant experts too, as the ~Tulip® enables bronchoscopy, endoscopy, endotracheal intubation and nasogastric/orogastric tube insertion through the ~Tulip® breathing tube. This then enables ongoing ventilation throughout the procedure, if the equipment is introduced appropriately through a sealed side-port.
Hence, the ~Tulip® airway is of assistance to everybody.
The ~Tulip® airway is small and very similar to a Guedel airway in size. ~Tulips® sit within the oropharynx and stimulate the glossopharyngeal nerve, to induce swallowing, rather than causing gagging, retching or vomiting, like much larger and much deeper seated supraglottic airway devices do by stimulating the superior laryngeal nerve within the laryngopharynx.
The ~Tulip® causes minimal patient stimulation and can be used in semi-conscious patients, which then facilitates fully awake self-extubation with the return of oropharyngeal reflexes. Multiple patients have been witnessed answering questions and talking through the airway tube of a ~Tulip® in-situ, with the cuff still fully inflated, and whilst the ~Tulip® continues to provide a fully ventilating airway.
Thus, there is also reduced obstruction upon extubation, as the ~Tulip’s® balloon-like cuff keeps the breathing tube centrally located within the oropharynx and the oral cavity whilst simultaneously wiping away some of the secretions with its soft, still fully inflated, balloon-like cuff (30 – 60mls, depending upon size).
This is a significant safety benefit, as this then reduces suctioning and subsequent trauma, in addition to its 100% ease of use, 77% user preference, lower cuff pressures (+/- 40mmHg/50cmH2O), higher average ventilation pressures (10 – 20cmH2O), lower peak ventilation pressures (< 20cmH2O), higher tidal volumes (+ 77%), higher oxygen concentrations (+/- 250%) and the multiple performance benefits that are derived from the hands-free and directly-connectable design that facilitates nasogastric/orogastric tubes, endoscopy, bronchoscopy and blind endotracheal intubation through the wide-bore ~Tulip® breathing tube that has been deliberately constructed to offer such facilities. These benefits then reduce manpower requirements and the over-all time spent by the patient in the Operating Theatre and Recovery Suite.
The problem is, the Guedel airway (1933) is not directly connectable, may require 1– 3 hands, 1 – 2 operators, and requires practiced Facemask skills for competent use. This is difficult for most users, whilst only providing 60 – 80% of diluted Oxygen (mask rebreathing) and uncontrolled peak-ventilation pressures (> 20cmH2O). Failure rates are also high (41.6%), as competent Facemask use is still, largely, an Anaesthetic skill.
Even other non-anaesthetic Doctors tend to perform poorly with the Guedel and Facemask technique.
Thus, the intention is to improve poor out of hospital (OOH) Cardiopulmonary Resuscitation (CPR) survival rates and allow anyone, anywhere to perform competent CPR upon anybody at any time. This includes Operating Theatres and Recovery settings, where the ~Tulip® airway can deliver approximately 85 – 92% of all starved elective anaesthetic airway requirements.
If you wish to purchase ~Tulip airways, simply go to the “Payments and Purchases” tab in the menu and order whatever size and quantity of ~Tulips you like. Freight charges will then be agreed with you once order size and delivery location have been received. Both speedy delivery and low cost can be accommodated. All communications are gratefully received to info@tulipairway.co.uk
The ~Tulip® is a small, oropharyngeal airway that directly replaces the Guedel and Facemask technique for all users and all first-line airway interventions, even in semi-conscious patients. This is not possible with any other ventilating airway, as the patient usually needs to be fully unconscious before any supraglottic devices can be introduced.
This is a major advantage, as early ~Tulip® use prevents any further patient deterioration in the first instance.
Equally, the ~Tulip® may be used for first-line airway intervention, starved-elective anaesthesia, endotracheal intubation, endoscopy or nasogastric and orogastric tube insertion. The ~Tulip’s® large, oropharyngeal, balloon-like cuff is particularly advantageous in ENT and Dental surgery, as no endotracheal intubation is required because the ~Tulip’s® large, 30 – 60ml, high-volume, low-pressure cuff produces an airtight seal within the oropharynx, e.g., above the laryngeal inlet and below the level of the surgery.
Clinical trials have shown statistically significant results with the inexperienced, first-time users generating 77% bigger tidal volumes, 101% higher end-tidal CO2 readings, 36% higher ventilation pressures, and no failures with the ~Tulip® airway. This translates into 125 – 250% more Oxygen with hands-free, direct-connectability and a reduced dead-space volume in times of acute emergency, as adequate ventilation was achieved in 60 out of 60 users (100%) with the ~Tulip® airway.
This was statistically significant in favour of the ~Tulip® airway at a p < 0.001 level.
The analysis of the binary outcome data showed that the outcome of adequate ventilation in less than 60 seconds and within 2 attempts was achieved with 35 out of 60 (58.3%) of Guedel and Facemask users, demonstrating 10 out of 60 (16.7%) total failures, and 15 out of 60 (25%) inadequately ventilated patients. The end-tidal CO2 and tidal-volume outcomes were achieved in 56 of the 60 (93%) users with the ~Tulip® airway, but in only 16 of the 60 users (27%) with the Guedel and Facemask combination (p < 0.001).
10 of the 60 Guedel and Facemask users (17%) failed to ventilate the patient at all.
End-tidal carbon dioxide, tidal volume and peak inspiratory pressures were significantly better (p < 0.0001) for all parameters with the ~Tulip® airway.
The ~Tulip® airway was found to be easier to insert and demonstrated a steep learning curve. Thus, the ~Tulip® airway device should be considered as an adjunct to airway management both inside and outside hospital because the data now clearly shows that the ~Tulip® does not just make the impossible possible, the ~Tulip® makes the impossible easy for everybody.
In terms of user preference, 47 out of 60 (78%) of users favoured the ~Tulip® airway.
This is a major advantage, as early ~Tulip® use prevents any further patient deterioration in the first instance.
Equally, the ~Tulip® may be used for first-line airway intervention, starved-elective anaesthesia, endotracheal intubation, endoscopy or nasogastric and orogastric tube insertion. The ~Tulip’s® large, oropharyngeal, balloon-like cuff is particularly advantageous in ENT and Dental surgery, as no endotracheal intubation is required because the ~Tulip’s® large, 30 – 60ml, high-volume, low-pressure cuff produces an airtight seal within the oropharynx, e.g., above the laryngeal inlet and below the level of the surgery.
Clinical trials have shown statistically significant results with the inexperienced, first-time users generating 77% bigger tidal volumes, 101% higher end-tidal CO2 readings, 36% higher ventilation pressures, and no failures with the ~Tulip® airway. This translates into 125 – 250% more Oxygen with hands-free, direct-connectability and a reduced dead-space volume in times of acute emergency, as adequate ventilation was achieved in 60 out of 60 users (100%) with the ~Tulip® airway.
This was statistically significant in favour of the ~Tulip® airway at a p < 0.001 level.
The analysis of the binary outcome data showed that the outcome of adequate ventilation in less than 60 seconds and within 2 attempts was achieved with 35 out of 60 (58.3%) of Guedel and Facemask users, demonstrating 10 out of 60 (16.7%) total failures, and 15 out of 60 (25%) inadequately ventilated patients. The end-tidal CO2 and tidal-volume outcomes were achieved in 56 of the 60 (93%) users with the ~Tulip® airway, but in only 16 of the 60 users (27%) with the Guedel and Facemask combination (p < 0.001).
10 of the 60 Guedel and Facemask users (17%) failed to ventilate the patient at all.
End-tidal carbon dioxide, tidal volume and peak inspiratory pressures were significantly better (p < 0.0001) for all parameters with the ~Tulip® airway.
The ~Tulip® airway was found to be easier to insert and demonstrated a steep learning curve. Thus, the ~Tulip® airway device should be considered as an adjunct to airway management both inside and outside hospital because the data now clearly shows that the ~Tulip® does not just make the impossible possible, the ~Tulip® makes the impossible easy for everybody.
In terms of user preference, 47 out of 60 (78%) of users favoured the ~Tulip® airway.
The ~Tulip® airway is a range of airway devices designed to allow anybody to resuscitate anyone anywhere. Even by family members and children > 8 yrs. of age because the ~Tulip® was specifically designed for both inexperienced and experienced users. This then allows life saving Basic Life Support (BLS) and Cardiopulmonary Resuscitation (CPR) intervention in any location.
Even in semi-conscious patients, or at home.
The ~Tulip® is a replacement for the Guedel and Facemask. It may be used for any airway intervention, including starved elective anaesthesia. The ~Tulip® is an oropharyngeal airway. It is not supraglottic. The ~Tulip® is much smaller in size. Therefore, the ~Tulip® may be used in semi-conscious patients because it is the smallest, softest (lowest cuff pressure), least invasive and least stimulating intermittent positive pressure ventilating (IPPV) airway available. The ~Tulip® is also hands-free and directly-connectable, which then allows the delivery of 100% O2 via a sealed-circuit for the provision of life support and airway maintenance. The ~ Tulip® is colour coded for size. It is available both with and without a headband.
The Objective
Airway management is usually conducted by medical professionals, but unfortunately most collapses and cardiac arrests happen outside the hospital, at home, where medical assistance is unlikely to arrive within the 3 – 5 minutes available. Consequently, everyone must be able to manage an airway and conduct BLS/CPR (Basic Life Support/Cardiopulmonary Resuscitation), otherwise the outcomes are likely to be negative because an uncomfortable fact is that out of hospital (OOH) cardiac arrest survival without neurological deficit is only 1.25 – 2.5% (10,000 patients over 10 years) at the moment.
The ~Tulip® is the first airway device designed for such wide-spread use, and as such the ~Tulip® may also be more easily used by medical professionals in Hospital settings. For example, in A+E/ER, on the Wards, by Paramedics in Ambulances, and for more complex cases such as starved elective anaesthesia because the ~Tulip® is the first airway that was designed for everybody.
The Guedel airway was invented in 1933. It is the hardest airway to use because of the difficult Facemask skills that are required, yet the least experienced airway users must still use it because no other alternatives have been available, until now.
The ~Tulip® airway addresses these issues head-on, as the ~Tulip® airway has been specifically designed to assist inexperienced users. However, the ~Tulip® is of benefit to consultant experts too, as the ~Tulip® enables bronchoscopy, endoscopy, endotracheal intubation and nasogastric/orogastric tube insertion through the ~Tulip® breathing tube. This then enables ongoing ventilation throughout the procedure, if the equipment is introduced appropriately through a sealed side-port.
Hence, the ~Tulip® airway is of assistance to everybody.
The ~Tulip® airway is small and very similar to a Guedel airway in size. ~Tulips® sit within the oropharynx and stimulate the glossopharyngeal nerve, to induce swallowing, rather than causing gagging, retching or vomiting, like much larger and much deeper seated supraglottic airway devices do by stimulating the superior laryngeal nerve within the laryngopharynx.
The ~Tulip® causes minimal patient stimulation and can be used in semi-conscious patients, which then facilitates fully awake self-extubation with the return of oropharyngeal reflexes. Multiple patients have been witnessed answering questions and talking through the airway tube of a ~Tulip® in-situ, with the cuff still fully inflated, and whilst the ~Tulip® continues to provide a fully ventilating airway.
Thus, there is also reduced obstruction upon extubation, as the ~Tulip’s® balloon-like cuff keeps the breathing tube centrally located within the oropharynx and the oral cavity whilst simultaneously wiping away some of the secretions with its soft, still fully inflated, balloon-like cuff (30 – 60mls, depending upon size).
This is a significant safety benefit, as this then reduces suctioning and subsequent trauma, in addition to its 100% ease of use, 77% user preference, lower cuff pressures (+/- 40mmHg/50cmH2O), higher average ventilation pressures (10 – 20cmH2O), lower peak ventilation pressures (< 20cmH2O), higher tidal volumes (+ 77%), higher oxygen concentrations (+/- 250%) and the multiple performance benefits that are derived from the hands-free and directly-connectable design that facilitates nasogastric/orogastric tubes, endoscopy, bronchoscopy and blind endotracheal intubation through the wide-bore ~Tulip® breathing tube that has been deliberately constructed to offer such facilities. These benefits then reduce manpower requirements and the over-all time spent by the patient in the Operating Theatre and Recovery Suite.
The problem is, the Guedel airway (1933) is not directly connectable, may require 1– 3 hands, 1 – 2 operators, and requires practiced Facemask skills for competent use. This is difficult for most users, whilst only providing 60 – 80% of diluted Oxygen (mask rebreathing) and uncontrolled peak-ventilation pressures (> 20cmH2O). Failure rates are also high (41.6%), as competent Facemask use is still, largely, an Anaesthetic skill.
Even other non-anaesthetic Doctors tend to perform poorly with the Guedel and Facemask technique.
Thus, the intention is to improve poor out of hospital (OOH) Cardiopulmonary Resuscitation (CPR) survival rates and allow anyone, anywhere to perform competent CPR upon anybody at any time. This includes Operating Theatres and Recovery settings, where the ~Tulip® airway can deliver approximately 85 – 92% of all starved elective anaesthetic airway requirements.
If you wish to purchase ~Tulip airways, simply go to the “Payments and Purchases” tab in the menu and order whatever size and quantity of ~Tulips you like. Freight charges will then be agreed with you once order size and delivery location have been received. Both speedy delivery and low cost can be accommodated. All communications are gratefully received to info@tulipairway.co.uk
International and World Wide Patents Granted | ~ Age of Aquarius | info@tulipairway.co.uk
International and World Wide Patents Granted -
Dr Amer Shaikh